Presenilins and neuronal calcium signaling
Presenilins and neuronal calcium signaling
批准号:
7915436
负责人:
Ilya B Bezprozvanny
金额:
$39.25万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-15 至 2012-07-31
关键词:
AccountingAffectAge-MonthsAlzheimer&aposs DiseaseAmyloid beta-ProteinAmyloid beta-Protein PrecursorApoptosisBrainCalciumCalcium SignalingCatalytic DomainCellsCleaved cellClinicalCysteineDataDementiaDependovirusElderlyEmbryoEndoplasmic ReticulumFibroblastsGenesGlutamatesGoalsHippocampus (Brain)HomeostasisImageImmunoassayIn Situ Nick-End LabelingInfectionInjection of therapeutic agentIntegral Membrane ProteinIonsKnock-outKnockout MiceLaboratoriesLinkLipid BilayersMapsMeasuresMethodsMissense MutationMusMutagenesisMutationNerve DegenerationNeuronsPathogenesisPathologyPathway interactionsPatientsPeptidesPhenotypePlayPresenile Alzheimer DementiaProductionPropertyReagentRoleScanningSenile PlaquesSignal TransductionStaining methodStainsSubfamily lentivirinaeSulfhydryl CompoundsSurfaceTestingTransgenic MiceTransmembrane DomainVirusage relatedamyloid precursor protein processingcalreticulinclinical phenotypefamilial Alzheimer diseasegamma secretaseimaging modalityin vivoknock-downlymphoblastmethanethiosulfonatemethanethiosulfonate ethylammoniummutantneuron lossoverexpressionpresenilinpresenilin-1presenilin-2reconstitutionresearch studysecretasetreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The broad, long-term objective of the project is to understand the importance of calcium (Ca2+) signaling in pathogenesis offamilial Alzheimer's disease (FAD), Presenilins are transmembrane proteins localized to endoplasmic reticulum (ER), Missense mutations in presenilin-1 (PS1) and presenilin-2 (PS2) account for 40% of FAD cases. Presenilins function as catalytic subunit of gamma-secretase which cleaves amyloid precursor protein (APP) and releases A-beta peptide, a principal component of amyloid plaques in AD brains. We recently discovered that presenilins also function as passive ER Ca2+ leak channels which control intraluminal ER Ca2+ concentration. Moreover, we found that many FAD-linked mutations in presenilins impair their ER Ca2+ leak channel function. Here I propose to further investigate the effects of FAD mutations in presenilins on their ER Ca2+ leak function in the context of AD pathology. Specifically, I propose: 1. To analyze effects of additional FAD mutations in presenilin-1 on ER Ca2+ leak function. The experiments with primary Iymphoblasts established from FAD patients and rescue experiments with PS double-knockout (DKO) mouse embryonic fibroblasts (MEF) will be performed. The main goal of these experiments will be to establish a correlation between clinical PS-FAD phenotypes with ER Ca2+ leak function of PS-FAD mutants. Obtained results will help to explain a variability of clinical phenotypes resulting from PS-FAD mutations. The results obtained in Ca2+ imaging experiments will be correlated with effects of the same PS-FAD mutations on Abeta42 and Abeta40 production measured by immunoassay. 2. To map the ion conduction pathway in PS1 by cysteine-scanning mutagenesis. I propose that the ion conduction pore of presenilin channels is formed by transmembrane domains 6, 7 and 9. To test this hypothesis, Cys point mutants will be introduced in transmembrane domains 6, 7 and 9 of mouse cysteine-less PS1 construct. The function of generated mPS1-Cys mutants will be evaluated in PS DKO MEF rescue experiments. The functional mPS1-Cys mutants will be expressed in Sf9 cells by baculoviral infection and reconstituted into planar lipid bilayers (BLM). The surface accessibility of introduced cysteine residues will be tested by applying thiol-specific modifying methanethiosulfonate (MTS) reagents (MTSEA, MTSET and MTSES) to the BLM. Results of these experiments will provide mechanistic information about critical determinants responsible for ion-conduction properties of presenilins. The results of proposed experiments will help to further establish the connection between FAD mutations in presenilins, disturbances in ER Ca2+ signaling and AD pathogenesis. These data will also help to evaluate "Ca2+ hypothesis of AD" and will contribute to selecting optimal strategies for treatment of AD.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1523/jneurosci.1554-10.2010
发表时间:
2010-06-23
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
[Zhang H, Sun S, Herreman A, De Strooper B, Bezprozvanny I]
通讯作者:
Bezprozvanny I
DOI:
10.1016/j.ceca.2009.12.014
发表时间:
2010-02
期刊:
Cell calcium
影响因子:
4
作者:
[Supnet C, Bezprozvanny I]
通讯作者:
Bezprozvanny I
Presenilins as endoplasmic reticulum calcium leak channels and Alzheimer's disease pathogenesis.
早老素作为内质网钙渗漏通道和阿尔茨海默氏病的发病机制。
DOI:
10.1007/s11427-011-4201-y
发表时间:
2011
期刊:
Science China. Life sciences
影响因子:
--
作者:
[Supnet,Charlene, Bezprozvanny,Ilya]
通讯作者:
Bezprozvanny,Ilya
DOI:
10.1016/j.ceca.2011.05.013
发表时间:
2011-09
期刊:
Cell calcium
影响因子:
4
作者:
[Supnet C, Bezprozvanny I]
通讯作者:
Bezprozvanny I
DOI:
10.3233/jad-2010-100306
发表时间:
2010
期刊:
Journal of Alzheimer's disease : JAD
影响因子:
--
作者:
[Supnet C, Bezprozvanny I]
通讯作者:
Bezprozvanny I
Sigma 1 receptor as therapeutic target for Alzheimers disease treatment
-
批准号:10901028
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2023
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Calcium dysregulation and vulnerability of entorhinal cortex neurons in Alzheimer's disease
-
批准号:10733805
-
项目类别:
-
资助金额:$73.08万
-
财政年份:2023
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Calcium dysregulation and vulnerability of entorhinal cortex neurons in Alzheimer's disease
-
批准号:10459711
-
项目类别:
-
资助金额:$69.82万
-
财政年份:2021
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Calcium signaling and synaptic maintenance in Alzheimers disease
-
批准号:9285585
-
项目类别:
-
资助金额:$296.45万
-
财政年份:2017
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Development of SK channel modulators as therapeutic agents for ataxia
-
批准号:10311149
-
项目类别:
-
资助金额:$72.31万
-
财政年份:2017
-
负责人:Ilya B Bezprozvanny
-
依托单位:
ConProject-001
-
批准号:10316591
-
项目类别:
-
资助金额:$72.31万
-
财政年份:2017
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Presenilins and neuronal calcium dyshomeostasis
-
批准号:9271268
-
项目类别:
-
资助金额:$45.91万
-
财政年份:2013
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Presenilins and neuronal calcium dyshomeostasis
-
批准号:8720077
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2013
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Presenilins and neuronal calcium dyshomeostasis
-
批准号:8632540
-
项目类别:
-
资助金额:$45.91万
-
财政年份:2013
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Calcium channels as novel therapeutic targets for Huntingtons Disease
-
批准号:8704830
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2012
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Calcium channels as novel therapeutic targets for Huntingtons Disease
-
批准号:8263938
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2012
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Calcium channels as novel therapeutic targets for Huntingtons Disease
-
批准号:8448608
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2012
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Presenilins and neuronal calcium signaling
-
批准号:7464974
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2009
-
负责人:Ilya B Bezprozvanny
-
依托单位:
2008 Calcium Signaling and Disease SGP Conference
-
批准号:7483558
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2008
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Deranged calcium signaling and polyglutamine expansion disorders
-
批准号:7992395
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2007
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Deranged calcium signaling and polyglutamine expansion disorders
-
批准号:7713544
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2007
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Deranged calcium signaling and polyglutamine expansion disorders
-
批准号:7372488
-
项目类别:
-
资助金额:$34.34万
-
财政年份:2007
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Deranged calcium signaling and polyglutamine expansion disorders
-
批准号:7872018
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2007
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Deranged calcium signaling and polyglutamine expansion disorders
-
批准号:9222808
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2007
-
负责人:Ilya B Bezprozvanny
-
依托单位:
Deranged calcium signaling and polyglutamine expansion disorders
-
批准号:8204671
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2007
-
负责人:Ilya B Bezprozvanny
-
依托单位:
海外基金